Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Swedish National Guidelines on Urothelial Carcinoma : 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma

Liedberg, Fredrik LU ; Kjellström, Sofia ; Lind, Anna-Karin ; Sherif, Amir ; Söderkvist, Karin ; Falkman, Karin ; Thulin, Helena ; Aljabery, Firas ; Papantonio, Dimitrious and Ströck, Viveka , et al. (2022) In Scandinavian Journal of Urology 56(2). p.137-146
Abstract

Objective: To overview the updated Swedish National Guidelines on Urothelial Carcinoma 2021, with emphasis on non-muscle-invasive bladder cancer (NMIBC) and upper tract urothelial carcinoma (UTUC). Methods: A narrative review of the updated version of the Swedish National Guidelines on Urothelial Carcinoma 2021 and highlighting new treatment recommendations, with comparison to the European Association of Urology (EAU) guidelines and current literature. Results: For NMIBC the new EAU 2021 risk group stratification has been introduced for non-muscle invasive bladder cancer to predict risk of progression and the web-based application has been translated to Swedish (https://nmibc.net.). For patients with non-BCG -responsive disease... (More)

Objective: To overview the updated Swedish National Guidelines on Urothelial Carcinoma 2021, with emphasis on non-muscle-invasive bladder cancer (NMIBC) and upper tract urothelial carcinoma (UTUC). Methods: A narrative review of the updated version of the Swedish National Guidelines on Urothelial Carcinoma 2021 and highlighting new treatment recommendations, with comparison to the European Association of Urology (EAU) guidelines and current literature. Results: For NMIBC the new EAU 2021 risk group stratification has been introduced for non-muscle invasive bladder cancer to predict risk of progression and the web-based application has been translated to Swedish (https://nmibc.net.). For patients with non-BCG -responsive disease treatment recommendations have been pinpointed, to guide patient counselling in this clinical situation. A new recommendation in the current version of the guidelines is the introduction of four courses of adjuvant platinum-based chemotherapy to patients with advanced disease in the nephroureterectomy specimen (pT2 or higher and/or N+). Patients with papillary urothelial neoplasms with low malignant potential (PUNLMP) can be discharged from follow-up already after 3 years based on a very low subsequent risk of further recurrences. Conclusions: The current version of the Swedish national guidelines introduces a new risk-stratification model and follow-up recommendation for NMIBC and adjuvant chemotherapy after radical surgery for UTUC.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
non-muscle invasive bladder cancer, Swedish national guidelines, upper tract urothelial carcinoma, Urothelial carcinoma
in
Scandinavian Journal of Urology
volume
56
issue
2
pages
137 - 146
publisher
Taylor & Francis
external identifiers
  • pmid:35225148
  • scopus:85125912554
ISSN
2168-1805
DOI
10.1080/21681805.2022.2041086
language
English
LU publication?
yes
id
524abf70-181e-4a2e-86c7-4ce0e0e1c80a
date added to LUP
2022-04-21 14:12:42
date last changed
2024-07-03 02:18:01
@article{524abf70-181e-4a2e-86c7-4ce0e0e1c80a,
  abstract     = {{<p>Objective: To overview the updated Swedish National Guidelines on Urothelial Carcinoma 2021, with emphasis on non-muscle-invasive bladder cancer (NMIBC) and upper tract urothelial carcinoma (UTUC). Methods: A narrative review of the updated version of the Swedish National Guidelines on Urothelial Carcinoma 2021 and highlighting new treatment recommendations, with comparison to the European Association of Urology (EAU) guidelines and current literature. Results: For NMIBC the new EAU 2021 risk group stratification has been introduced for non-muscle invasive bladder cancer to predict risk of progression and the web-based application has been translated to Swedish (https://nmibc.net.). For patients with non-BCG -responsive disease treatment recommendations have been pinpointed, to guide patient counselling in this clinical situation. A new recommendation in the current version of the guidelines is the introduction of four courses of adjuvant platinum-based chemotherapy to patients with advanced disease in the nephroureterectomy specimen (pT2 or higher and/or N+). Patients with papillary urothelial neoplasms with low malignant potential (PUNLMP) can be discharged from follow-up already after 3 years based on a very low subsequent risk of further recurrences. Conclusions: The current version of the Swedish national guidelines introduces a new risk-stratification model and follow-up recommendation for NMIBC and adjuvant chemotherapy after radical surgery for UTUC.</p>}},
  author       = {{Liedberg, Fredrik and Kjellström, Sofia and Lind, Anna-Karin and Sherif, Amir and Söderkvist, Karin and Falkman, Karin and Thulin, Helena and Aljabery, Firas and Papantonio, Dimitrious and Ströck, Viveka and Öfverholm, Elisabeth and Jerlström, Tomas and Sandzen, Johan and Verbiene, Ingrida and Ullén, Anders}},
  issn         = {{2168-1805}},
  keywords     = {{non-muscle invasive bladder cancer; Swedish national guidelines; upper tract urothelial carcinoma; Urothelial carcinoma}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{137--146}},
  publisher    = {{Taylor & Francis}},
  series       = {{Scandinavian Journal of Urology}},
  title        = {{Swedish National Guidelines on Urothelial Carcinoma : 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma}},
  url          = {{http://dx.doi.org/10.1080/21681805.2022.2041086}},
  doi          = {{10.1080/21681805.2022.2041086}},
  volume       = {{56}},
  year         = {{2022}},
}